Endocrinology

>

Latest News

Phase 3 data show effectiveness of somapacitan in children with growth disorders | Image Credit: © Saiful52- © Saiful52  - stock.adobe.com.
Phase 3 data show effectiveness of somapacitan in children with growth disorders

May 15th 2025

Somapacitan was non-inferior and had a similar safety profile and clinical outcomes compared to once-daily somatropin in improving yearly growth rates.

Puberty discussion with adults and child | Image Credit: ©  fizkes - stock.adobe.com.
Poll shows many parents unsure when to talk to kids about puberty

April 22nd 2025

Diabetes device data may fail to deliver based on smartphone settings | Image Credit: © KRISTINA KUPTSEVICH - © KRISTINA KUPTSEVICH - stock.adobe.com.
Diabetes device data may fail to deliver based on smartphone settings

February 5th 2025

Afrezza inhaled insulin meets primary endpoint in phase 3 pediatric diabetes trial | Image Credit: © Africa Studio - © Africa Studio - stock.adobe.com.
Afrezza inhaled insulin meets primary endpoint in phase 3 pediatric diabetes trial

December 20th 2024

COVID-19 among adolescents, teens and type 2 diabetes incidence | Image Credit: © Production Perig - © Production Perig - stock.adobe.com.
COVID-19 among adolescents, teens and type 2 diabetes incidence

November 20th 2024

Video Interviews
Podcasts

More News

© 2025 MJH Life Sciences

All rights reserved.